It seems we can’t find what you’re looking for. Perhaps searching can help.
Nothing found
Latest Articles
-
Hoth Therapeutics Expands HT-001 Development with Patent Filings Targeting Drug-Induced Hypersensitivity, Radiotherapy-Induced Rash, and MENIN Inhibitor-Associated Skin Toxicities
September 25, 2025 Comments Off on Hoth Therapeutics Expands HT-001 Development with Patent Filings Targeting Drug-Induced Hypersensitivity, Radiotherapy-Induced Rash, and MENIN Inhibitor-Associated Skin ToxicitiesMENIN inhibitors are a promising class of targeted oncology drugs in development for acute leukemias and certain solid tumors, but their use is often limited by severe dermatological side effects. HT-001 aims to address these [...] -
September 25, 2025 Comments Off on Worksport (NASDAQ: WKSP) Corporate Update: Record Margins, Strategic Expansion, Imminent Product Launch
-
September 25, 2025 Comments Off on Wellgistics Health (NASDAQ: WGRX) Launches Capital Access Program for 6,500+ Pharmacies and Supply Chain Partners, Unlocking up to $1M in Working Capital
-
September 22, 2025 Comments Off on Advent Technologies (NASDAQ: ADN) Delivers State-of-the-Art Portable Fuel Cell Systems under Contract with the U.S. Department of Defense
-
September 15, 2025 Comments Off on “Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP)
Popular Articles
-
Hoth Therapeutics Expands HT-001 Development with Patent Filings Targeting Drug-Induced Hypersensitivity, Radiotherapy-Induced Rash, and MENIN Inhibitor-Associated Skin Toxicities
September 25, 2025 Comments Off on Hoth Therapeutics Expands HT-001 Development with Patent Filings Targeting Drug-Induced Hypersensitivity, Radiotherapy-Induced Rash, and MENIN Inhibitor-Associated Skin ToxicitiesMENIN inhibitors are a promising class of targeted oncology drugs in development for acute leukemias and certain solid tumors, but their use is often limited by severe dermatological side effects. HT-001 aims to address these [...] -
February 9, 2009 Comments Off on Post 2
-
February 9, 2009 Comments Off on Palm(NASDAQ: PALM) builds momentum;
-
February 9, 2009 Comments Off on Post 4
-
February 10, 2009 Comments Off on Value Investing Opportunities (Prospect List Here)